Articles written by: Ralph Creech

Edge Therapeutics Inc. (EDGE)’s Financial Results Comparing With Pfenex Inc. (NYSEAMERICAN:PFNX)

This is a contrast between Edge Therapeutics Inc. (NASDAQ:EDGE) and Pfenex Inc. (NYSEAMERICAN:PFNX) based on their profitability, analyst recommendations, risk, institutional ownership, dividends, earnings and valuation. The two companies are Biotechnology and they also compete with each other. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

United Technologies Corporation (UTX)’s Financial Results Comparing With L3 Technologies Inc. (NYSE:LLL)

Both United Technologies Corporation (NYSE:UTX) and L3 Technologies Inc. (NYSE:LLL) are Aerospace/Defense Products & Services companies, competing one another. We will compare their profitability, institutional ownership, analyst recommendations, risk, dividends, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio United Technologies Corporation […]

Contrasting of Curis Inc. (CRIS) and Mustang Bio Inc. (NASDAQ:MBIO)

We will be comparing the differences between Curis Inc. (NASDAQ:CRIS) and Mustang Bio Inc. (NASDAQ:MBIO) as far as institutional ownership, earnings and valuation, profitability, risk, dividends, analyst recommendations are concerned. The two businesses are rivals in the Biotechnology industry. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per […]

Reviewing Genocea Biosciences Inc. (GNCA)’s and Spero Therapeutics Inc. (NASDAQ:SPRO)’s results

Both Genocea Biosciences Inc. (NASDAQ:GNCA) and Spero Therapeutics Inc. (NASDAQ:SPRO) are Biotechnology companies, competing one another. We will contrast their dividends, institutional ownership, analyst recommendations, profitability, risk, earnings and valuation. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Genocea Biosciences Inc. N/A 0.00 27.81M […]

Comparing of Hemispherx Biopharma Inc. (HEB) and Cellect Biotechnology Ltd. (NASDAQ:APOP)

Hemispherx Biopharma Inc. (NYSEAMERICAN:HEB) and Cellect Biotechnology Ltd. (NASDAQ:APOP) compete against each other in the Biotechnology sector. We will contrast them and contrast their analyst recommendations, profitability, risk, dividends, earnings and valuation, institutional ownership. Valuation & Earnings Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hemispherx Biopharma […]

Comparison of vTv Therapeutics Inc. (VTVT) and Gamida Cell Ltd. (NASDAQ:GMDA)

vTv Therapeutics Inc. (NASDAQ:VTVT) and Gamida Cell Ltd. (NASDAQ:GMDA) have been rivals in the Biotechnology for quite some time. Below is a review of each business including various aspects such as institutional ownership, profitability, risk, dividends, analyst recommendations, earnings and valuation. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income […]

Baker Hughes a GE company (BHGE) and Recon Technology Ltd. (NASDAQ:RCON) Comparison side by side

Both Baker Hughes a GE company (NYSE:BHGE) and Recon Technology Ltd. (NASDAQ:RCON) are each other’s competitor in the Oil & Gas Equipment & Services industry. Thus the contrast of their institutional ownership, analyst recommendations, profitability, risk, dividends, earnings and valuation. Valuation and Earnings Gross Revenue Price/Sales Ratio Net Income Earnings […]

Contrasting of Replimune Group Inc. (REPL) and MyoKardia Inc. (NASDAQ:MYOK)

Replimune Group Inc. (NASDAQ:REPL) and MyoKardia Inc. (NASDAQ:MYOK) compete against each other in the Biotechnology sector. We will contrast them and contrast their risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Replimune Group Inc. […]

Comparing of Neurocrine Biosciences Inc. (NBIX) and Cara Therapeutics Inc. (NASDAQ:CARA)

This is therefore a comparing of the dividends, analyst recommendations, profitability, institutional ownership, risk, earnings and valuation in Neurocrine Biosciences Inc. (NASDAQ:NBIX) and Cara Therapeutics Inc. (NASDAQ:CARA). The two are both Biotechnology companies that compete with one another. Earnings & Valuation Gross Revenue Price/Sales Ratio Net Income Earnings Per Share […]

Kindred Biosciences Inc. (KIN) and Innoviva Inc. (NASDAQ:INVA) Contrasting side by side

Kindred Biosciences Inc. (NASDAQ:KIN) and Innoviva Inc. (NASDAQ:INVA), are influenced by compare since they are both players in the Biotechnology. These factors are particularly influence the dividends, analyst recommendations, profitability, risk, institutional ownership, earnings and valuation of the two firms. Earnings and Valuation Gross Revenue Price/Sales Ratio Net Income Earnings […]